AnandKGanesanMD

Dermatology • Irvine, CA

Assistant Professor, Dermatology, University of California, Irvine College of Medicine

Join to view full profile

Dr. Ganesan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ganesan's full profile

Already have an account?

Office
1 Medical Plaza Drive
Gottschalk Medical Plaza
Irvine, CA 92697
Phone+1 949-824-0606

Education & Training

University of Texas Southwestern Medical CenterResidency, Dermatology, 2002 - 2005
St Mary Medical CenterInternship, Internal Medicine, 2001 - 2002
Medical College of WisconsinClass of 2001

Certifications & Licensure

CA State Medical License 2003 - 2025
TX State Medical License 2005 - 2007
American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transpl...
Iltefat H Hamzavi, Anand K Ganesan, Bassel H Mahmoud, Eduardo Weiss, Ammar M Ahmed
Journal of the American Academy of Dermatology. 2024-12-01
1 citations
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, Paola Facheris, Jonathan Bar
Archives of Dermatological Research. 2024-07-18
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy.
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti
Journal of Medicinal Chemistry. 2024-06-27

Press Mentions

Study Finds New Way to Reduce Inflammation and Prevent Repigmentation in Patients with Vitiligo DiseaseJuly 7th, 2022
Study Finds New Way to Reduce Inflammation and Prevent Repigmentation in Patients with Vitiligo DiseaseJuly 7th, 2022
Melanoma Researcher Covers All the BasesJune 6th, 2022
Join now to see all

Grant Support

Aldehyde Dehydrogenase: A Novel Regulator Of Melanin BiogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2012
Dissecting The Impact Of Autophagy Regulators On Melanogenesis In Normal Human CENational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011